{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:27:12Z","timestamp":1792441632366,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.schres.2025.04.024","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T20:58:54Z","timestamp":1745873934000},"page":"10-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Autoimmune psychosis: Psychopathological patterns and outcome after immunotherapy"],"prefix":"10.1016","volume":"281","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2879-5258","authenticated-orcid":false,"given":"Jesus","family":"Ramirez-Bermudez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Espinola-Nadurille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Restrepo-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Mart\u00ednez-\u00c1ngeles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Mart\u00ednez-Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lissy","family":"Cascante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Valdeiglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monserrat","family":"Mondrag\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jazm\u00edn","family":"Armenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josu\u00e9 Garc\u00eda","family":"Alm\u00e1nzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Rivas-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Flores-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Arias-Carri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas A.","family":"Pollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2025.04.024_bb0005","first-page":"5620","article-title":"Psychosis in systemic lupus erythematosus (SLE): 40-year experience of a specialist Centre","volume":"60","author":"Abrol","year":"2021","journal-title":"Rheumatol. (United Kingdom)"},{"key":"10.1016\/j.schres.2025.04.024_bb0010","doi-asserted-by":"crossref","DOI":"10.1111\/imm.12795","article-title":"Psychosis: an autoimmune disease?","author":"Al-Diwani","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.schres.2025.04.024_bb0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S2215-0366(19)30001-X","article-title":"The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data","volume":"6","author":"Al-Diwani","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2025.04.024_bb0020","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fith","author":"American Psychiatric Association","year":"2022"},{"key":"10.1016\/j.schres.2025.04.024_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2023.107701","article-title":"Cognitive follow-up in anti-N-methyl-D-aspartate receptor encephalitis: hospital discharge, 4, 8, and 12 months","volume":"228","author":"Bayliss","year":"2023","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.schres.2025.04.024_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1196110","article-title":"Therapy response in seronegative versus seropositive autoimmune encephalitis","volume":"14","author":"Berger","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.schres.2025.04.024_bb0035","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/13546805.2023.2266872","article-title":"The association between visual hallucinations and secondary psychosis: a systematic review and meta-analysis","volume":"28","author":"Blackman","year":"2023","journal-title":"Cogn. Neuropsychiatr."},{"key":"10.1016\/j.schres.2025.04.024_bb0040","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.schres.2025.04.024_bb0045","article-title":"Neuropsychiatric phenotypes of anti-NMDAR encephalitis: a prospective study. Psychological Medicine 2022","volume":"1\u20139","author":"Espinola-Nadurille","year":"2022","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2025.04.024_bb0050","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1017\/S0033291722001027","article-title":"Neuropsychiatric phenotypes of anti-NMDAR encephalitis: a prospective study","volume":"53","author":"Espinola-Nadurille","year":"2023","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2025.04.024_bb0055","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/pcn.12658","article-title":"Cotard\u2019s syndrome in anti- N -methyl- d -aspartate receptor encephalitis","volume":"72","author":"Funayama","year":"2018","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2025.04.024_bb0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/WNN.0000000000000375","article-title":"The cotard delusion in a patient with neuropsychiatric systemic lupus erythematosus: the challenges of autoimmune psychosis","volume":"37","author":"Garc\u00eda-Sarre\u00f3n","year":"2024","journal-title":"Cogn. Behav. Neurol."},{"key":"10.1016\/j.schres.2025.04.024_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1176\/appi.neuropsych.17120343","article-title":"The psychiatric phenotype of Anti-NMDA receptor encephalitis","volume":"31","author":"Gibson","year":"2018","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.schres.2025.04.024_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.schres.2025.04.024_bb0075","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1212\/WNL.0000000000012191","article-title":"Clinical, neuroimmunologic, and CSF investigations in first episode psychosis","volume":"97","author":"Guasp","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.schres.2025.04.024_bb0080","first-page":"1","article-title":"Red flags: clinical signs for identifying autoimmune encephalitis in psychiatric patients","volume":"8","author":"Herken","year":"2017","journal-title":"Front. Psychol."},{"key":"10.1016\/j.schres.2025.04.024_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114420","article-title":"The factor structure and clinical utility of clinician-rated dimensions of psychosis symptom severity in patients with recent-onset psychosis: results of a 1-year longitudinal follow-up prospective cohort study","volume":"310","author":"Jeong","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2025.04.024_bb0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.schres.2019.11.023","article-title":"Prevalence of N-Methyl-D-Aspartate Receptor antibody (NMDAR-Ab) encephalitis in patients with first episode psychosis and treatment resistant schizophrenia on clozapine, a population based study","volume":"222","author":"Kelleher","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2025.04.024_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2013.00863","article-title":"Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs","volume":"4","author":"Lakens","year":"2013","journal-title":"Front. Psychol."},{"key":"10.1016\/j.schres.2025.04.024_bb0100","series-title":"Europe PMC Funders Group Prevalence and Clinical Characteristics of Serum Neuronal Cell Surface Antibodies in First-episode Psychosis: A Case-control Study","first-page":"42","volume":"4","author":"Lennox","year":"2018"},{"key":"10.1016\/j.schres.2025.04.024_bb0105","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12026-024-09457-w","article-title":"Blood and CSF anti-neuronal antibodies testing in psychotic syndromes: a retrospective analysis from a tertiary psychiatric hospital","volume":"72","author":"Lopes","year":"2024","journal-title":"Immunol. Res."},{"key":"10.1016\/j.schres.2025.04.024_bb0110","article-title":"Capgras delusion in anti-NMDAR encephalitis: a case of autoimmune psychosis","volume":"102208","author":"Lozano-Cuervo","year":"2020","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.schres.2025.04.024_bb0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/acn.12013","article-title":"Psychiatric phenomena as initial manifestation of encephalitis by anti-NMDAR antibodies","volume":"25","author":"Maat","year":"2013","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.schres.2025.04.024_bb0120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.psym.2013.06.002","article-title":"Psychiatric manifestations of Anti-NMDA receptor encephalitis: neurobiological underpinnings and differential diagnostic implications","volume":"55","author":"Maneta","year":"2014","journal-title":"Psychosomatics"},{"key":"10.1016\/j.schres.2025.04.024_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1067-y","article-title":"A clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis","volume":"15","author":"Najjar","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.schres.2025.04.024_bb0130","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.schres.2025.04.024_bb0135","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jamaneurol.2021.3188","article-title":"Use and safety of immunotherapeutic management of N-Methyl-d-Aspartate Receptor antibody encephalitis: a meta-analysis","volume":"78","author":"Nosadini","year":"2021","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.schres.2025.04.024_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41582-019-0174-4","article-title":"Immunoneuropsychiatry \u2014 novel perspectives on brain disorders","author":"Pape","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.schres.2025.04.024_bb0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2215-0366(19)30290-1","article-title":"Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin","volume":"7","author":"Pollak","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.schres.2025.04.024_bb0150","first-page":"140","article-title":"Frequency of neuropsychiatric signs and symptoms in patients with viral encephalitis","volume":"41","author":"Ram\u00edrez-Berm\u00fadez","year":"2005","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.schres.2025.04.024_bb0155","first-page":"222","article-title":"Examining the features of neuroleptic malignant syndrome in Anti-NMDA receptor encephalitis: a case-control study","volume":"65","author":"Ramirez-Bermudez","year":"2024","journal-title":"J. Acad. Consult. Psychiatr."},{"key":"10.1016\/j.schres.2025.04.024_bb0160","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/13546805.2019.1676710","article-title":"FDG-PET in Cotard syndrome before and after treatment: can functional brain imaging support a two-factor hypothesis of nihilistic delusions?","volume":"24","author":"Restrepo-Mart\u00ednez","year":"2019","journal-title":"Cogn. Neuropsychiatr."},{"key":"10.1016\/j.schres.2025.04.024_bb0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.genhosppsych.2020.03.003","article-title":"Delirious mania as a frequent and recognizable neuropsychiatric syndrome in patients with anti-NMDAR encephalitis","volume":"64","author":"Restrepo-Martinez","year":"2020","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.024_bb0170","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000208026","article-title":"Immunotherapy in autoimmune encephalitis: so many options, so few guidelines","author":"Srivastava","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.schres.2025.04.024_bb0175","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1176\/appi.neuropsych.20220200","article-title":"Suicidal thoughts and behaviors in anti-NMDA receptor encephalitis: psychopathological features and clinical outcomes","volume":"35","author":"Tellez-Martinez","year":"2023","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.schres.2025.04.024_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-021-01701-3","article-title":"Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis","volume":"11","author":"Theorell","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.schres.2025.04.024_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-N-methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.schres.2025.04.024_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.schres.2025.04.024_bb0195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/WCO.0000000000001048","article-title":"Immunotherapy in autoimmune encephalitis","volume":"35","author":"Trewin","year":"2022","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.schres.2025.04.024_bb0200","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"Van Swieten","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.schres.2025.04.024_bb0205","doi-asserted-by":"crossref","DOI":"10.1111\/acps.12941","article-title":"Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis","author":"Warren","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2025.04.024_bb0210","article-title":"Psychiatric management of anti-NMDAR encephalitis: a cohort analysis","volume":"1\u20136","author":"Warren","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2025.04.024_bb0215","series-title":"Disease-relevant Autoantibodies in First Episode Schizophrenia","first-page":"686","author":"Zandi","year":"2011"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996425001549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996425001549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:04:28Z","timestamp":1774530268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996425001549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":43,"alternative-id":["S0920996425001549"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2025.04.024","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune psychosis: Psychopathological patterns and outcome after immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2025.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}